0
Abstract: Poster Presentations |

SMOKER↓S PARADOX IN CLOPIDOGREL EFFICACY? THE IMPACT OF SMOKING STATUS ON CLOPIDOGREL PRETREATMENT EFFICACY IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION FREE TO VIEW

Zuzana Motovska, MD*; Petr Widimsky, MD; Robert Petr, MD; Dana Bilkova, MD; Iuri Marinov, MD; Stanislav Simek, MD; Petr Kala, MD
Author and Funding Information

3rd Medical School Charles University, Prague, Czech Republic


Chest


Chest. 2008;134(4_MeetingAbstracts):p84001. doi:10.1378/chest.134.4_MeetingAbstracts.p84001
Text Size: A A A
Published online

Abstract

PURPOSE:Clopidogrel requires conversion with cytochrome P450 to an active metabolite. High interindividual variability in the drug efficacy is well known. The aim of this analysis was to identify factors that influence the efficacy of 600mg clopidogrel pretreatment in patients with stable coronary artery disease undergoing elective PCI.

METHODS:In the laboratory substudy of the PRAGUE-8 trial (ClinicalTrials.gov identifier NCT00432120), the time course of platelet inhibition was investigated in 105 patients pretreated with clopidogrel ≥6h before coronary angiography±PCI. Flow cytometric analysis of the vasodilator stimulated phosphoprotein (VASP) phosphorylation state was performed, and a Platelet Reactivity Index (PRI) was calculated before, and 12, 28, 36, 60, 84 and 108h after, 600mg of clopidogrel. The influences of age, sex, BMI>30, hypertension, hyperlipidemia, diabetes mellitus, tobacco smoking, renal insufficiency, statin, heparin and aspirin therapy on the course of clopidogrel efficacy were investigated using logistic regression analysis.

RESULTS:Diabetes was associated with the highest baseline platelet reactivity to adenosine diphosphate (ADP). The time-curve of the 600mg clopidogrel-mediated inhibition of platelet reactivity had a downward trend until 28h after the drug administration. At 12 hours, 47% of patients had PRI ≥50% (mean (SD) value 45 (21) %). After adjustments for all investigated factors, tobacco smoking was independent predictor for the most robust drop in ADP-induced platelet reactivity at this time point (p=0.027). In contrast, the lowest decrease in PRI was seen in obese patients and those with diabetes (p=0.1). The maximal inhibition of ADP-induced platelet reactivity was achieved by 28h after drug; PRI mean for all patients 36± 23%, for smokers 28±13%. Logistic regression showed that the magnitude of total PRI decrease at 28 hours was not significantly influenced by cigarette smoking (p=0.12).

CONCLUSION:Cigarette smoke is independently associated with a prompt antiplatelet response to clopidogrel.

CLINICAL IMPLICATIONS:This could imply an association between tobacco smoke and CYP3AY and 3A5 induction. Is there a relationship between this observation and the published better outcomes of smokers after primary PCI?

DISCLOSURE:Zuzana Motovska, No Financial Disclosure Information; No Product/Research Disclosure Information

Wednesday, October 29, 2008

1:00 PM - 2:15 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543